Ngā hua rapu - Lisa Pieri
- E whakaatu ana i te 1 - 20 hua o te 37
- Haere ki te Whārangi Whai Ake
-
1
-
2
-
3
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera mā Lisa Pieri, Costanza Bogani, Paola Guglielmelli, Maria Zingariello, R. A. Rana, Niccolò Bartalucci, Alberto Bosi, Alessandro M. Vannucchi
I whakaputaina 2009Artigo -
4
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia mā Giada Rotunno, Carmela Mannarelli, Paola Guglielmelli, Annalisa Pacilli, Alessandro Pancrazzi, Lisa Pieri, Tiziana Fanelli, Alberto Bosi, Alessandro M. Vannucchi
I whakaputaina 2013Artigo -
5
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib mā Lisa Pieri, Alessandro Pancrazzi, Annalisa Pacilli, Claudia Rabuzzi, Giada Rotunno, Tiziana Fanelli, Paola Guglielmelli, Rajmonda Fjerza, Chiara Paoli, Srđan Verstovšek, Alessandro M. Vannucchi
I whakaputaina 2015Carta -
6
Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia mā Elisabetta Antonioli, Paola Guglielmelli, G Poli, Costanza Bogani, Alessandro Pancrazzi, Giovanni Longo, Vanessa Ponziani, Lorenzo Tozzi, Lisa Pieri, Valeria Santini, Alberto Bosi, Alessandro M. Vannucchi
I whakaputaina 2007Artigo -
7
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value mā A.M. Vannucchi, Giada Rotunno, Niccolò Bartalucci, G Raugei, Valentina Carrai, Manjola Balliu, Anna Gallì, Annalisa Pacilli, Laura Calabresi, Rajmonda Fjerza, Lisa Pieri, Alberto Bosi, Rossella Manfredini, Paola Guglielmelli
I whakaputaina 2014Artigo -
8
Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome–Negative Myeloproliferative Neoplasms mā Alessandro M. Vannucchi, Giovanna Masala, Elisabetta Antonioli, Maria Chiara Susini, Paola Guglielmelli, Lisa Pieri, Laura Maggi, Saverio Caini, Domenico Palli, Costanza Bogani, Vanessa Ponziani, Alessandro Pancrazzi, Francesco Annunziato, Alberto Bosi
I whakaputaina 2009Artigo -
9
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results mā Srđan Verstovšek, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Elisa Rumi, Elisabetta Gattoni, Lisa Pieri, Hui‐Ling Zhen, Muriel Granier, Albert Assad, Mario Cazzola, Hagop M. Kantarjian, Tiziano Barbui, Alessandro M. Vannucchi
I whakaputaina 2017Carta -
10
The effect of arterial hypertension on thrombosis in low‐risk polycythemia vera mā Tiziano Barbui, Alessandro M. Vannucchi, Alessandra Carobbio, Elisa Rumi, Guido Finazzi, Heinz Gisslinger, Marco Ruggeri, Maria Luigia Randi, Mario Cazzola, Alessandro Rambaldi, Bettina Gisslinger, Lisa Pieri, Jüergen Thiele, Animesh Pardanani, Ayalew Tefferi
I whakaputaina 2016Carta -
11
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele mā Paola Guglielmelli, Giovanni Barosi, Giorgina Specchia, Alessandro Rambaldi, Francesco Lo‐Coco, Elisabetta Antonioli, Lisa Pieri, Alessandro Pancrazzi, Vanessa Ponziani, Federica Delaini, Giovanni Longo, Emanuele Ammatuna, Vincenzo Liso, Alberto Bosi, Tiziano Barbui, Alessandro M. Vannucchi
I whakaputaina 2009Artigo -
12
In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology mā Tiziano Barbui, Alessandra Carobbio, Elisa Rumi, Guido Finazzi, Heinz Gisslinger, Francesco Rodeghiero, Maria Luigia Randi, Alessandro Rambaldi, Bettina Gisslinger, Lisa Pieri, Irene Bertozzi, Ilaria Carola Casetti, Animesh Pardanani, Francesco Passamonti, Alessandro M. Vannucchi, Ayalew Tefferi
I whakaputaina 2014Carta -
13
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts mā Francesco Passamonti, Margherita Maffioli, Francisco Cervantes, Alessandro M. Vannucchi, Enrica Morra, Tiziano Barbui, Domenica Caramazza, Lisa Pieri, Elisa Rumi, Heinz Gisslinger, Laurent Knoops, Jean‐Jacques Kiladjian, Barbara Mora, Norbert Hollaender, Cristiana Pascutto, Claire Harrison, Mario Cazzola
I whakaputaina 2014Artigo -
14
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study mā Paola Guglielmelli, Flavia Biamonte, Giada Rotunno, Valentina Artusi, Lucia Artuso, Isabella Bernardis, Elena Tenedini, Lisa Pieri, Chiara Paoli, Carmela Mannarelli, Rajmonda Fjerza, Elisa Rumi, Viktoriya Stalbovskaya, Matthew Squires, Mario Cazzola, Rossella Manfredini, Claire Harrison, Enrico Tagliafico, Alessandro M. Vannucchi
I whakaputaina 2014Artigo -
15
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression mā Thorsten Klampfl, Ashot S. Harutyunyan, Tiina Berg, Bettina Gisslinger, Martin Schalling, Klaudia Bagienski, Damla Olcaydu, Francesco Passamonti, Elisa Rumi, Daniela Pietra, Roland Jäger, Lisa Pieri, Paola Guglielmelli, Ilaria Iacobucci, Giovanni Martinelli, Mario Cazzola, Alessandro M. Vannucchi, Heinz Gisslinger, Róbert Královics
I whakaputaina 2011Artigo -
16
A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea mā Srđan Verstovšek, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Peter J. Rosen, Elisa Rumi, Elisabetta Gattoni, Lisa Pieri, Paola Guglielmelli, Chiara Elena, Shui He, Nancy Contel, Bijoyesh Mookerjee, Victor Sandor, Mario Cazzola, Hagop M. Kantarjian, Tiziano Barbui, Alessandro M. Vannucchi
I whakaputaina 2013Artigo -
17
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis mā Ayalew Tefferi, Terra L. Lasho, Omar Abdel‐Wahab, Paola Guglielmelli, Jay Patel, Domenica Caramazza, Lisa Pieri, Christy Finke, Outi Kilpivaara, Martha Wadleigh, Ming Mai, Rebecca F. McClure, D. Gary Gilliland, Ross L. Levine, Animesh Pardanani, Alessandro M. Vannucchi
I whakaputaina 2010Artigo -
18
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms mā Elena Tenedini, Isabella Bernardis, Valentina Artusi, Lucia Artuso, Enrica Roncaglia, Paola Guglielmelli, Lisa Pieri, Costanza Bogani, Flavia Biamonte, Giada Rotunno, C Mannarelli, Elisa Bianchi, Alessandro Pancrazzi, Tiziana Fanelli, Guidantonio Malagoli Tagliazucchi, Sérgio Ferrari, Rossella Manfredini, Alessandro M. Vannucchi, Enrico Tagliafico
I whakaputaina 2013Artigo -
19
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera mā Federico Lussana, Alessandra Carobbio, Maria Luigia Randi, Chiara Elena, Elisa Rumi, Guido Finazzi, Irene Bertozzi, Lisa Pieri, Marco Ruggeri, Francesca Palandri, Nicola Polverelli, Elena Maria Elli, Alessia Tieghi, Alessandra Iurlo, Marco Ruella, Mario Cazzola, Alessandro Rambaldi, Alessandro M. Vannucchi, Tiziano Barbui
I whakaputaina 2014Artigo -
20
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis mā Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy Finke, Emnet A Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Jüergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi
I whakaputaina 2014Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Bone marrow
Myelofibrosis
Polycythemia vera
Essential thrombocythemia
Gastroenterology
Biology
Immunology
Gene
Genetics
Oncology
Thrombosis
Surgery
Confidence interval
Physics
Platelet
Ruxolitinib
Cancer research
Incidence (geometry)
Mutation
Optics
Thrombocytosis
Cohort
Hazard ratio
Myeloid
Myeloproliferative neoplasm
Disease
Leukemia
Adverse effect